Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · IEX Real-Time Price · USD
8.79
+0.09 (1.03%)
At close: May 17, 2024, 3:59 PM
8.70
-0.09 (-1.02%)
After-hours: May 17, 2024, 4:00 PM EDT
Addex Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Addex Therapeutics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ADXN.
Recommendation Trends
| Rating | Feb '22 | Mar '22 | Apr '22 | May '22 | Jun '22 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 23, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $420 → $300 | Strong Buy | Maintains | $420 → $300 | +3,312.97% | May 31, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $560 → $420 | Strong Buy | Maintains | $560 → $420 | +4,678.16% | Feb 11, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $560 | Strong Buy | Initiates | $560 | +6,270.88% | Apr 21, 2021 |
Financial Forecast
Revenue This Year
3.21M
from 1.65M
Increased by 95.07%
Revenue Next Year
10.97M
from 3.21M
Increased by 241.27%
EPS This Year
-0.11
from -0.14
EPS Next Year
0.04
from -0.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.6M | 21.0M | n/a |
| Avg | 3.2M | 11.0M | n/a |
| Low | n/a | 1.5M | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 301.6% | 553.6% | - |
| Avg | 95.1% | 241.3% | - |
| Low | - | -54.2% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.09 | 0.22 | -0.10 |
| Avg | -0.11 | 0.04 | -0.10 |
| Low | -0.12 | -0.12 | -0.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.